Cargando…
Nomegestrol acetate/17-beta estradiol: a review of efficacy, safety, and patient acceptability
Nomegestrol acetate (NOMAC) 2.5 mg with 17-beta estradiol (E2) 1.5 mg is a new combined oral contraceptive (COC) formulation and is the first monophasic E2 pill to be marketed, having been licensed for use in Europe in 2011. It is available to be taken daily in a regimen of 24 active pills followed...
Autores principales: | Akintomide, Hannat, Panicker, Sabeena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683186/ https://www.ncbi.nlm.nih.gov/pubmed/29386925 http://dx.doi.org/10.2147/OAJC.S61942 |
Ejemplares similares
-
Nomegestrol acetate-17b-estradiol for oral contraception
por: Burke, Anne
Publicado: (2013) -
Does Nomegestrol Acetate Plus 17β-Estradiol Oral Contraceptive Improve Endometriosis-Associated Chronic Pelvic Pain in Women?
por: Caruso, Salvatore, et al.
Publicado: (2020) -
The effectiveness of quick starting oral contraception containing nomegestrol acetate and 17-β estradiol on ovulation inhibition: A randomized controlled trial
por: Jirakittidul, Preeyaporn, et al.
Publicado: (2020) -
Preclinical pharmacological profile of nomegestrol acetate, a synthetic 19-nor-progesterone derivative
por: van Diepen, Harry A
Publicado: (2012) -
Modeling the Photocatalytic Mineralization in Water of Commercial Formulation of Estrogens 17-β Estradiol (E2) and Nomegestrol Acetate in Contraceptive Pills in a Solar Powered Compound Parabolic Collector
por: Colina-Márquez, José, et al.
Publicado: (2015)